November 19, 2018

[FEATURED] FDA Guidance Looks At Benefit Vs. Risk In Certain 510(k)s

A newly finalized guidance document from US FDA explains how the agency will evaluate benefit and risk questions for substantially equivalent products with differing technological characteristics.

Do you like it?0

Named the #1 Regulatory Services Company 2022 by Life Sciences Review